Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Titan Pharmaceuticals Inc TTNP

Healthcare
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The... see more

Recent & Breaking News (NDAQ:TTNP)

Titan Pharmaceuticals Reports Second Quarter 2017 Financial Results

PR Newswire August 9, 2017

Titan Pharmaceuticals Schedules Conference Call To Review Second Quarter 2017 Financial Results

PR Newswire August 2, 2017

Titan Pharmaceuticals Secures $10 Million Debt Facility From Horizon Technology Finance

PR Newswire July 27, 2017

Titan Pharmaceuticals and Walter Reed Army Institute of Research Collaborate to Evaluate ProNeura Antimalarial Implants

PR Newswire July 6, 2017

Fortune Article Highlights Titan Pharmaceuticals And Its ProNeura Technology

PR Newswire June 29, 2017

Titan Pharmaceuticals Reports First Quarter 2017 Financial Results

PR Newswire May 10, 2017

Titan Pharmaceuticals Schedules Conference Call To Review First Quarter 2017 Financial Results

PR Newswire May 4, 2017

Titan Pharmaceuticals Reports Full Year And Fourth Quarter 2016 Financial Results

PR Newswire March 16, 2017

Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2016 Financial Results

PR Newswire March 10, 2017

Titan Pharmaceuticals To Present At 29th Annual ROTH Conference

PR Newswire March 7, 2017

Titan Pharmaceuticals Receives FDA Communication On Ropinirole Implant Investigational New Drug Application

PR Newswire February 27, 2017

Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech

PR Newswire February 13, 2017

Braeburn Pharmaceuticals' Probuphine® Implant Receives J-Code by Centers for Medicare & Medicaid Services

PR Newswire January 13, 2017

Titan Pharmaceuticals Appoints Two New Board Members

PR Newswire January 4, 2017

Braeburn Pharmaceuticals and CEO Behshad Sheldon Win Stevie Awards for Best New Product or Service and Female Executive of the Year

PR Newswire November 21, 2016

Titan Pharmaceuticals Reports Third Quarter 2016 Financial Results

Marketwired November 9, 2016

Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2016 Financial Results

Marketwired November 3, 2016

Titan Pharmaceuticals, Inc. (Nasdaq: TTNP) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire November 1, 2016

Probuphine® Implant for Opioid Dependence Featured at 2016 International Society of Addiction Medicine Meeting

PR Newswire October 28, 2016

Popular Science Recognizes Probuphine as One of the 2016 "Best of What's New"

Marketwired October 20, 2016